Papers in Surgical Oncology Insight
Page 3 · newest first
- Risk factors for early versus late venous thromboembolism after cytoreductive surgery and HIPECSurgical Oncology Insight · 2024
- Analysis of 3144 case reports in the gastrointestinal stromal tumor literature: Identification of underappreciated demographics, clinical presentations, and biologySurgical Oncology Insight · 2024
- Utility of tumor-informed circulating tumor DNA for detection of minimal residual disease after curative-intent therapy in localized pancreatic cancerSurgical Oncology Insight · 2024
- Outcomes of minimally invasive and open prophylactic gastrectomy for hereditary diffuse gastric cancerSurgical Oncology Insight · 2024
- Impact of an online risk prediction tool for sentinel node metastasis on clinical decision-making in melanoma care: A mixed methods studySurgical Oncology Insight · 2024
- Effect of travel distance on outcomes of patients with malignant peritoneal mesothelioma treated with cytoreductive surgery and hyperthermic intraperitoneal chemotherapySurgical Oncology Insight · 2024
- Outcomes of mediastinal envelope closure during minimally invasive esophagectomySurgical Oncology Insight · 2024
- Real-world analysis of neuroendocrine tumor misdiagnosis and associated costsSurgical Oncology Insight · 2024
- Variability in treatment approaches, outcomes, and recurrence patterns after curative intent treatment for primary retroperitoneal sarcomas in Latin America: A report on 333 patients from LATAMSARC collaborative working groupSurgical Oncology Insight · 2024
- Is pancreatic adenosquamous carcinoma (PASC) a surgical disease? A large healthcare system reviewSurgical Oncology Insight · 2024
- Systemic inflammatory markers: Predictors of survival in mucinous appendix cancer patients treated with cytoreductive surgery and hyperthermic intraperitoneal chemotherapySurgical Oncology Insight · 2024
- Combining liver-directed and immunotherapy in advanced hepatocellular carcinoma: A review and future directionsSurgical Oncology Insight · 2024
- Immunotherapy in gastroesophageal adenocarcinoma: What is the state of management?Surgical Oncology Insight · 2024
- Pelvic Floor Physical Therapy Prehabilitation (PrePFPT) for the prevention of low anterior resection syndromeSurgical Oncology Insight · 2024
- How reliable are post-mastectomy breast reconstruction videos on YouTube?Surgical Oncology Insight · 2024
- Adjuvant breast radiation therapy practice patterns in the United States from 2012–2017Surgical Oncology Insight · 2024
- DNA mismatch repair deficiency as a biomarker in sarcomaSurgical Oncology Insight · 2024
- Laparoscopic versus robotic pancreaticoduodenectomy: A NSQIP analysis comparing trends in patient selection and outcomes over 5-yearsSurgical Oncology Insight · 2024
- Nerve graft reconstruction of irradiated oncologic segmental nerve defects in the extremities: A case seriesSurgical Oncology Insight · 2024
- Is it time to de-escalate axillary surgery in patients with ductal carcinoma in-situ undergoing mastectomy?Surgical Oncology Insight · 2024
- The evolution of breast ultrasound in surgical practice: Current applications, missed opportunities, and future directionsSurgical Oncology Insight · 2024
- Pepsinogen and Helicobacter pylori: Serum biomarkers for gastric cancer risk in a diverse United States populationSurgical Oncology Insight · 2024
- Anxiety and Depression are Common in Surgical Oncology Patients: Results of a Prospective Cohort StudySurgical Oncology Insight · 2024
- Association between warfarin and survival in invasive melanoma: a population-based cohort studySurgical Oncology Insight · 2024
- Understanding the cancer health literacy gap: NCCN member institutions’ website readability across the high mortality cancers in the USSurgical Oncology Insight · 2024
- Minimum number of lymph nodes to maximize survival in non-metastatic appendiceal adenocarcinomaSurgical Oncology Insight · 2024
- Strategies for reoperative parathyroidectomySurgical Oncology Insight · 2024
- Hyperthermic Intraperitoneal Chemotherapy (HIPEC) vs. Postoperative Intraperitoneal (IP) Chemotherapy - Impact on Health-Related Quality of Life in Primary Ovarian Cancer Patients after Cytoreductive SurgerySurgical Oncology Insight · 2024
- Evolving patterns of metastatic spread, treatment, and outcome for patients with oligometastatic colorectal cancerSurgical Oncology Insight · 2024
- Risk factors of a positive resection margin in locoregional appendix cancer and its impact on survival: The national cancer database analysisSurgical Oncology Insight · 2024
- Travel distance does not affect overall survival in patients with appendiceal adenocarcinoma undergoing cytoreductive surgery and hyperthermic intraperitoneal chemotherapySurgical Oncology Insight · 2024
- Disaggregating U.S. Asian and Pacific Islanders: Colorectal cancerSurgical Oncology Insight · 2024
- Interference with activities of daily living according to pain level after breast surgerySurgical Oncology Insight · 2024
- Incidence and survival of Extramammary Paget’s Disease from the Surveillance, Epidemiology, and End Results (SEER) databaseSurgical Oncology Insight · 2024
- The impact of a bloodless medicine program on pancreatic resections: A single-institution experience incorporating patients with borderline-resectable and locally advanced pancreatic cancerSurgical Oncology Insight · 2024
- Minimally invasive training in surgical oncology: Current status and needs assessmentSurgical Oncology Insight · 2024
- Expanding the use of nipple sparing mastectomy: A review of the indications and techniquesSurgical Oncology Insight · 2024
- Clinicopathological features and short-term surgical outcomes of early-onset versus late-onset colorectal cancer at a tertiary hospital in Tanzania: A retrospective-cohort studySurgical Oncology Insight · 2024
- The neoadjuvant approach to treatment of breast cancer: Multidisciplinary management to improve outcomesSurgical Oncology Insight · 2024
- Enhancing the National Cancer Database content using natural language processing and electronic health record dataSurgical Oncology Insight · 2024
- Role of locoregional therapy in gastric cancer with peritoneal metastasisSurgical Oncology Insight · 2024
- Safety and margin positivity rates of surgeon-performed intraoperative ultrasound-guided wire localization for breast cancerSurgical Oncology Insight · 2024
- Trends in incidence of oral cavity squamous cell carcinoma in the United States 2001-2019Surgical Oncology Insight · 2024
- Trends in socioeconomic inequalities in pancreatic cancer mortality in Canada: Evidence from the Canadian Vital Statistics Death DatabaseSurgical Oncology Insight · 2024
- Transhiatal esophagectomy after major thoracic surgery. Don’t give up too soon!Surgical Oncology Insight · 2024
- Contemporary trends in breast cancer in females under the age of fifty: An NCDB studySurgical Oncology Insight · 2024
- Phase I dose escalation study for In Vivo Lung Perfusion (IVLP) as an adjuvant treatment for patients with resectable pulmonary metastasis of bone or soft tissue sarcomasSurgical Oncology Insight · 2024
- Implementation of the 2015 American Thyroid Association guideline changes across a health system: A quality improvement opportunitySurgical Oncology Insight · 2024
- Intra-pleural and intra-peritoneal tocilizumab therapy for managing malignant pleural effusions and ascites: The Regional Immuno-Oncology Trial (RIOT)−2 study protocolSurgical Oncology Insight · 2024
- Malignant bowel obstruction: Historical lessons, current trends, and future directionsSurgical Oncology Insight · 2024